211 related articles for article (PubMed ID: 20364043)
21. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
[TBL] [Abstract][Full Text] [Related]
22. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy.
Yoon SY; Kim JS; Jung SW; Kim YG; Hwang HS; Moon JY; Lee SH; Seo JW; Seok J; Tae D; Jeong K
Sci Rep; 2023 Oct; 13(1):17201. PubMed ID: 37821628
[TBL] [Abstract][Full Text] [Related]
24. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
Fan Q; Lu R; Zhu M; Yan Y; Guo X; Qian Y; Zhang L; Dai H; Ni Z; Gu L
Nephron; 2019; 142(3):195-207. PubMed ID: 30808829
[TBL] [Abstract][Full Text] [Related]
25. MicroRNAs in IgA nephropathy.
Yao X; Zhai Y; An H; Gao J; Chen Y; Zhang W; Zhao Z
Ren Fail; 2021 Dec; 43(1):1298-1310. PubMed ID: 34547971
[TBL] [Abstract][Full Text] [Related]
26. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy.
Duan ZY; Cai GY; Li JJ; Bu R; Chen XM
Kidney Blood Press Res; 2017; 42(4):738-748. PubMed ID: 29050002
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
Zununi Vahed S; Omidi Y; Ardalan M; Samadi N
Clin Biochem; 2017 Jan; 50(1-2):32-39. PubMed ID: 27521993
[TBL] [Abstract][Full Text] [Related]
28. Plasma microRNA signature of patients with IgA nephropathy.
Wu J; Zhang H; Wang W; Zhu M; Qi LW; Wang T; Cheng W; Zhu J; Shan X; Huang Z; Zhang L; Chen Y; Sun B; Zhao X; Qian J; Zhu W; Zhou X; Xing C
Gene; 2018 Apr; 649():80-86. PubMed ID: 29459010
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
31. Renal miR-148b is associated with megalin down-regulation in IgA nephropathy.
Wen L; Zhao Z; Xiao J; Wang Z; He X; Birn H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355654
[TBL] [Abstract][Full Text] [Related]
32. Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.
Zhai Y; Qi Y; Long X; Dou Y; Liu D; Cheng G; Xiao J; Liu Z; Zhao Z
J Cell Mol Med; 2019 Nov; 23(11):7299-7309. PubMed ID: 31557418
[TBL] [Abstract][Full Text] [Related]
33. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
[TBL] [Abstract][Full Text] [Related]
34. Mapping novel immunogenic epitopes in IgA nephropathy.
Woo SH; Sigdel TK; Dinh VT; Vu MT; Sarwal MM; Lafayette RA
Clin J Am Soc Nephrol; 2015 Mar; 10(3):372-81. PubMed ID: 25542908
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathological correlation between urinary exosome miR-223 and IgAN patients.
Song J; Qin X; Li H; Huang G; Bi H
Clin Nephrol; 2023 Nov; 100(5):209-215. PubMed ID: 37622669
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy.
Tan K; Chen J; Li W; Chen Y; Sui W; Zhang Y; Dai Y
Genome; 2013 Mar; 56(3):161-9. PubMed ID: 23659700
[TBL] [Abstract][Full Text] [Related]
37. MiR-320 promotes B cell proliferation and the production of aberrant glycosylated IgA1 in IgA nephropathy.
Li C; Shi J; Zhao Y
J Cell Biochem; 2018 Jun; 119(6):4607-4614. PubMed ID: 29266359
[TBL] [Abstract][Full Text] [Related]
38. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
[TBL] [Abstract][Full Text] [Related]
39. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]